Simultaneous separation of different types of amphetamine and piperazine designer drugs by capillary electrophoresis with a chiral selector

Journal of Forensic Sciences

Volumn 50, Issue 2, 2005, Pages 326-335

  Bishop, Sandra C ^a   McCord, Bruce R ^b   Gratz, Samuel R ^c   Loeliger, Jill R ^c   Witkowski, Mark R ^c  

^a OHIO UNIVERSITY   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Amphetamines; Benzylpiperazines; Capillary electrophoresis; Chiral separation; Forensic science

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 1 BENZYLPIPERAZINE DERIVATIVE; 2 HYDROXYPROPYL BETA CYCLODEXTRIN; AMPHETAMINE; DESIGNER DRUG; PIPERAZINE DERIVATIVE;

ARTICLE; CAPILLARY ELECTROPHORESIS; CHIRALITY; DRUG DETERMINATION; LABORATORY TEST; PRIORITY JOURNAL; SAMPLING; SCREENING; SEPARATION TECHNIQUE; TOXICOLOGY; ULTRAVIOLET RADIATION;

EID: 14844312045     PISSN: 00221198     EISSN: None     Source Type: Journal    
DOI: 10.1520/jfs2004239     Document Type: Article

References (32)

1. U.S. Department of Justice Drug Enforcement Administration, Federal Register. 2002;67, No. 183:59161.
2. de Boer D, Bosman IJ, Hidvegi E, Manzoni C, Benko AA, dos Reys LJAL, et al. Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market. Forensic Sci Int 2001;121:47-56.
3. Forensic Drug Abuse Advisor Inc. Legal ecstasy (MDMA)? Forensic Drug Abuse Advisor 2001;13(8):60.
4. U.S. Drug Enforcement Administration. BZP and TFMPP: chemicals used to mimic MDMA's effects, Drug Intelligence Brief. Washington, D.C.: U.S. Drug Enforcement Administration, December 2001.
5. Ecstasy and club drug trafficking in the pacific northwest. Microgram Bulletin 2004;37(1):17.
6. Tancer M, Johanson CE. The subject effects of MDMA and mCPP in moderate MDMA users. Drug and Alcohol Dependence 2001;65:97-101.
7. Tancer M, Johanson CE. Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP. Drug and Alcohol Dependence 2003;72:33-44.
8. di Tella AS, di Nunzio C, Ricci P. Determination of Trazodone and Its Metabolite, m-CPP, in Serum and Urine by HPLC. J Anal Toxicol 1986;10:233-35.
9. Vatassery GT, Holden LA, Hazel DK, Dysken MW. Determination of Trazodone and its metabolite 1-m-Chlorophenyl-piperazine, in Human plasma and red blood cell samples by HPLC. Cinical Biochemistry 1997;30(2):149-53.
10. Kennett GA, Whitton P, Shah K, Curzon G. Anxiogenic-like effects of mCCP and TFMPP in animal models are opposed by 5-HT1c receptor antagonists. Eur J Pharmacol 1989;164(3):445-54.
11. Wallis CJ, Lal H. A discriminative stimulus produced by 1-(3-chlorophenyl)piperazine (mCPP) as a putative animal model of anxiety. Prog Neuro-Psychopharmacol & Biol Psychiat 1998;22:547-65.
12. White SR. Amphetamine toxicity. Seminars in Respiratory and Critical Care Medicine 2002;23(1):27-36.
13. Moore K. Amphetamines/sympathomimetic amines. In: Levine B, editor. Principles of forensic toxicology. Washington, DC: American Association for Clinical Chemistry, Inc., 1999;65-285.
14. U.S. Drug Enforcement Administration. An overview of club drugs. Drug intelligence brief. Washington, D.C.: U.S. Drug Enforcement Administration, February 2000.
15. Piperazine mixture tablets. Microgram Bulletin 2003;36(1):6-10.
16. Tablets Containing Mixed Piperazines in Algona, Iowa. Microgram Bulletin 2003;36(6):118-9.
17. Mixed MDMA/piperazine tablets in San Diego, California. Microgram Bulletin 2003;36(7):153.
18. http://www.erowid.org/experiences/exp.php?ID=3567
19. http://www.fda.gov/bbs/topics/news/2004/NEW01036.html
20. Tella SR. Drug evaluation and scheduling process. Proceedings of the 56th Annual Meeting of the American Academy of Forensic Sciences; 2004 Feb. 16-21; Dallas. Colorado Springs, CO: American Academy of Forensic Sciences, 2004.
21. Staack RF, Fritschi G, Maurer HH. Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry. J Chromatogr B 2002;773:35-46.
22. Peters FT, Schaefer S, Staack RF, Kraemer T, Maurer HH. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. J Mass Spectrom 2003;38:659-76.
23. Varesio E, Veuthey JL. Chiral separation of amphetamines by high-performance capillary electrophoresis. J Chromatogr A 1995;717:219-28.
24. Iwata YT, Garcia A, Kanamori T, Inoue H, Kishi T, Lurie IS. The use of a highly sulfated cyclodextrin for the simultaneous chiral separation of amphetamine-type stimulants by capillary electrophoresis. Electrophoresis 2002;23:1328-34.
25. Tagliaro F, Manetto G, Bellini S, Scarcella D, Smith FP, Marigo M. Simultaneous chiral separation of MDMA, MDA, MDE, ephedrine, amphetamine and methamphetamine by capillary electrophoresis in uncoated and coated capillaries with native β-cyclodextrin as the chiral selector: Preliminary application to the analysis of urine and hair. Electrophoresis 1998;19:42-50.
26. Ramseier A, Caslavska J, Thormann W. Steroselective screening for and confirmation of urinary enantiomers of amphetamine, methamphetamine, designer drugs, methadone and selected metabolites by capillary electrophoresis. Electrophoresis 1999;20:2726-38.
27. Cheng W-C, Lee W-M, Chan M-F, Tsui P, Dao K-L. Enantiomeric separation of methamphetamine and related analogs by capillary zone electrophoresis: intelligence study in routine methamphetamine seizures. J Foresnic Sci 2002;47:1248-52.
28. Boatto G, Faedda MV, Pau A, Asproni B, Menconi S, Cerri R. Determination of amphetamines in human whole blood by capillary electrophoresis with photodiode array detection. J Pharm and Biomedical Anal 2002;29:1073-80.
29. Guttman A. Capillary electrophoresis separation of enantiomers by cyclodextrin array chiral analysis. In: Landers JP, editor. Handbook of capillary electrophoresis. Boca Raton: CRC Press, 1997;75-100.
30. Kinberger B. Sensitive method for the high-performance liquid chromatographic determination of amphetamine in urinary extracts. J Chromatogr 1981;213:166-9.
31. M2707 Varian Bond Elut Procedure for Amphetamines in Urine. Varian: Certify methods manual. Harbor City, CA: Varian, Inc., Jan 2001;13.
32. Advanced chemistry development (ACD) software Solaris [computer program]. V4.67 (© 1994-2003 ACD) SciFinder Scholar Version: 2001.